Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nubia S Lobato"'
Autor:
Graziela N Hagihara, Nubia S Lobato, Fernando P Filgueira, Eliana H Akamine, Danielle S Aragão, Dulce E Casarini, Maria Helena C Carvalho, Zuleica B Fortes
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e106029 (2014)
It has been clearly established that mitogen-activated protein kinases (MAPKS) are important mediators of angiotensin II (Ang II) signaling via AT1 receptors in the vasculature. However, evidence for a role of these kinases in changes of Ang II-induc
Externí odkaz:
https://doaj.org/article/8b22e6817af74c458bbd56d40d9657de
Autor:
Nubia S Lobato, Fernando P Filgueira, Roshini Prakash, Fernanda R Giachini, Adviye Ergul, Maria Helena C Carvalho, R Clinton Webb, Rita C Tostes, Zuleica B Fortes
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63449 (2013)
Impaired vascular function, manifested by an altered ability of the endothelium to release endothelium-derived relaxing factors and endothelium-derived contracting factors, is consistently reported in obesity. Considering that the endothelium plays a
Externí odkaz:
https://doaj.org/article/b4fc5b2595e54f02b8056e0e9004b202
Autor:
Karla B Neves, Nubia S Lobato, Aurelie D Nguyen, Rheure A Lopes, Katie Y Hood, Fabiola L Mestriner, Ana M Oliveira, Augusto C Montezano, Rhian M Touyz, Rita C Tostes
Publikováno v:
Hypertension. 66
Adipose tissue releases many adipokines, including chemerin, which produces its effects through activation of chemokine-like receptor 1 (ChemR23). Chemerin influences major aspects of the metabolic syndrome, including adipogenesis and insulin sensiti
Autor:
Karla B Neves, Nubia S Lobato, Rheure A Lopes, Fabiola L Mestriner, Ana Maria Oliveira, Rita C Tostes
Publikováno v:
Hypertension. 64
Proinflammatory adipokines are key mediators of insulin resistance. The adipokine chemerin influences major aspects of the metabolic syndrome, including adipogenesis and glucose homeostasis in adipocytes and skeletal muscle cells. Amongst its many ac
Autor:
Hagihara, Graziela N.1, Lobato, Nubia S.2, Filgueira, Fernando P.2, Akamine, Eliana H.1, Aragão, Danielle S.3, Casarini, Dulce E.3, Carvalho, Maria Helena C.1, Fortes, Zuleica B.1 zbfortes@icb.usp.br
Publikováno v:
PLoS ONE. Aug2014, Vol. 9 Issue 8, p1-10. 10p.
Autor:
Lobato, Nubia S.1,2,3, Filgueira, Fernando P.1,2,3, Prakash, Roshini2, Giachini, Fernanda R.2, Ergul, Adviye2, Carvalho, Maria Helena C.3, Webb, R. Clinton2, Tostes, Rita C.4, Fortes, Zuleica B.3 zbfortes@icb.usp.br
Publikováno v:
PLoS ONE. May2013, Vol. 8 Issue 5, p1-11. 11p.
Publikováno v:
NewsRx COVID-19 Weekly; 2/24/2023, p18-18, 1p
Autor:
Neves, Karla B, Lobato, Nubia S, Lopes, Rheure A, Mestriner, Fabiola L, Oliveira, Ana Maria, Tostes, Rita C
Publikováno v:
Hypertension (0194911X); 2014 Supplement, Vol. 64, pA276-A276, 1p
Autor:
Neves, Karla B, Lopes, Rheure A, Nguyen, Aurelie D, Lobato, Nubia S, Oliveira, Ana Maria, Montezano, Augusto C, Tostes, Rita C, Touyz, Rhian M
Publikováno v:
Hypertension (0194911X); 2014 Supplement, Vol. 64, pA101-A101, 1p
Angiotensin-converting enzyme (ACE) is a well-known zinc-metallopeptidase that converts angiotensin I to the potent vasoconstrictor angiotensin II and degrades bradykinin, a powerful vasodilator, both for the regulation of vascular tone and cardiac f